SEMAGLUTIDE (Rybelsus®)

Clinical Indication

Type 2 diabetes

Date of classification

September 2020

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.